{"title": "Reevaluating pneumococcal vaccine guidance: An analysis", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "Reevaluating pneumococcal vaccine guidance: An analysis"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190304100002.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190304100002.htm", "summary": "If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would likely be effective guidance.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/vaccines.xml", "value": "If mitigating racial disparities in those who contract pneumococcal diseases, such as meningitis and pneumonia, is a top public health priority, then recommending that all adults get a pneumococcal vaccine at age 50 would likely be effective guidance."}, "published": "Mon, 04 Mar 2019 10:00:02 EST", "published_parsed": [2019, 3, 4, 15, 0, 2, 0, 63, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190304100002.htm", "guidislink": false}